Drug firms cut prices to aid developing nations
8 просмотров
25.07.2012
00:03:47
Описание
A number of leading drug firms have announced plans to cut prices dramatically for life-saving drugs in the developing world. UK-based Glaxo Smithkline, says it will slash the cost of its Rotarix vaccine by 67% - it will now cost $5 to immunise a child against rotavirus, a leading cause of diarrhoea. Al Jazeera spoke to Paul Cook, the head of advocacy at Tearfund.
Комментарии